May 11, 2023
Retinal occlusion and spike proteins
There is no significant evidence linking mRNA COVID vaccines to retinal blood vessel damage, and vaccination is still recommended.
May 11, 2023
Mo’ vaccine, mo’ COVID?
More COVID vaccination does not increase infection risk; boosters are effective in preventing illness and severe outcomes.
May 11, 2023
Flu vaccination and other respiratory ailments
A small, potentially biased study suggesting flu vaccines increase non-influenza respiratory illness is contradicted by a larger study showing no such association.
May 11, 2023
Correcting this week’s misinformation: week of May 11, 2023
This week we take a look at whether flu vaccines render you 4.4 times more likely to get respiratory illnesses, if vaccinated people are more likely to get COVID-19 and what’s up with retinal occlusion caused by spike proteins.
May 6, 2023
Correcting this week’s misinformation: week of May 4, 2023
This week we take a look at whether SV40 is in mRNA vaccines, if the COVID vaccines really injure 1 in 800 people, and we unwind more claims about vaccines during pregnancy.
May 4, 2023
Vaccination and pregnancy
Adverse events during vaccine trials include anything negative that happens, often unrelated to the vaccine, and data show COVID vaccines are safe during pregnancy and breastfeeding, while COVID infection poses significant risks during pregnancy.
May 4, 2023
One in 800
Claims of a 1 in 800 serious adverse event rate from COVID vaccines are flawed, with studies showing vaccine benefits far outweigh the risks.
May 4, 2023
SV40 again
There is no credible evidence that mRNA COVID vaccines contain the cancer-causing SV40 virus, despite recent claims.
April 28, 2023
Correcting this week’s misinformation: week of April 27, 2023
This week was busy! We took a look at claims about Jamie Foxx and the COVID-19 vaccine, claims that public health officials tricked us into getting vaccines, and RSV in adults.
April 27, 2023
RSV in adults
The adult RSV vaccines under development have shown promising results in clinical trials, showing an efficacy of about 85% without safety concerns.
